The mean age at diagnosis is 40-50 years and the most common cause is a GH-secreting pituitary adenoma. A majority (nearly 75%) of patients with acromegaly will have a pituitary macroadenoma (>10 mm) ...

Affected populations: Acromegaly is estimated to affect approximately 50 to 70 people out of every million. However, the true figure may be higher, as the symptoms develop slowly and thus may go ...

with acromegaly. Patients received somatostatin analogs as primary therapy. They were assessed clinically, biologically and radiologically at the time of diagnosis, 6 months after starting ...

Those two hormones combined resulted in the symptoms Kohn experienced. Parts of the body, especially bones, just keep growing. A person with acromegaly will also experience fluid retention ...

It was designed to be a once daily oral option for the control of acromegaly and the symptoms related to carcinoid syndrome. In Phase 3 studies, once-daily, oral paltusotine maintained IGF-1 ...